Skip to content
Thursday, 13 August 2026

The Ledger Asia

Trusted Insights. Asian Perspective.

Subscribe
Latest News
Korea Investment Holdings’ KDB Life Bid Signals Insurance ConsolidationDeepSeek’s V4 API Price Increase Tests the Economics of Low-Cost AIAirAsia’s RM527 Million Quarterly Loss Exposes Fuel and Currency PressureMalaysia’s Connected Healthcare Push Moves Digital Integration Into ExecutionViu–TrueVisions Deal Expands Thai Content’s Regional Streaming EconomicsSK Hynix’s Vast AI Buildout Raises the Stakes for Korea’s Memory LeadershipGoogle’s First Overseas Store Makes Tokyo a Test Bed for AI-Enabled RetailPharmaniaga Q2 Net Profit Triples to RM13 Million on Higher APPL Demand and Debt ReductionKorea Investment Holdings’ KDB Life Bid Signals Insurance ConsolidationDeepSeek’s V4 API Price Increase Tests the Economics of Low-Cost AIAirAsia’s RM527 Million Quarterly Loss Exposes Fuel and Currency PressureMalaysia’s Connected Healthcare Push Moves Digital Integration Into ExecutionViu–TrueVisions Deal Expands Thai Content’s Regional Streaming EconomicsSK Hynix’s Vast AI Buildout Raises the Stakes for Korea’s Memory LeadershipGoogle’s First Overseas Store Makes Tokyo a Test Bed for AI-Enabled RetailPharmaniaga Q2 Net Profit Triples to RM13 Million on Higher APPL Demand and Debt Reduction

Pharmaniaga Q2 Net Profit Triples to RM13 Million on Higher APPL Demand and Debt Reduction

By Abigail Cheong2 min read

Shah Alam, 13 August 2026 – Pharmaceutical group Pharmaniaga Berhad posted a sharp earnings recovery for the second quarter ended 30 June 2026 (Q2 FY2026), with net profit more than tripling to RM13.0 million, supported by increased government hospital orders, stronger private sector demand, and reduced debt servicing costs.

Group revenue for Q2 FY2026 rose 12.3 percent year-on-year to RM1.04 billion from RM926.9 million in the corresponding quarter last year. For the cumulative six-month period (1H FY2026), Pharmaniaga recorded total revenue of RM2.22 billion, up 12.0 percent from RM1.98 billion, while profit after tax expanded 31.2 percent to RM45.2 million compared to RM34.5 million in 1H FY2025.

Unlock the Full Article

This article is exclusive to The Ledger Asia Subsribers / PAID members.

Subscribe to Read More

Already have an account? Log in here

This content has been restricted to logged-in users only. Please log in to view this content.

Author

  • I am Abigail, a journalist at The Ledger Asia, covering business and finance with a focus on the Malaysian Stock Market and key economic developments across Asia. Known for clear, accessible reporting, I deliver insights that help readers understand market trends, corporate movements, and regional news shaping the Asian economy.